Loading clinical trials...
Loading clinical trials...
Radiation therapy is an integral part of the multimodal primary therapy of glioblastomas. As the overall prognosis in this tumor entity remains unfavorable, current research is focused on additional d...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital Heidelberg
NCT07003542 · Glioblastoma, Brain Tumor
NCT05902169 · Glioblastoma, Recurrent Glioblastoma, and more
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT07274397 · Glioblastoma, Brain Tumors, and more
Universitätsklinikum Heidelberg
Heidelberg
Universitätsklinikum Gießen und Marburg
Marburg
Klinikum Stuttgart
Stuttgart
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions